Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Inhibitor Therapeutics, Inc. | d328204d10k.htm |
| EX-31.2 - EXHIBIT 31.2 - Inhibitor Therapeutics, Inc. | d328204dex312.htm |
| EX-32.2 - EXHIBIT 32.2 - Inhibitor Therapeutics, Inc. | d328204dex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Inhibitor Therapeutics, Inc. | d328204dex321.htm |
| EX-31.1 - EXHIBIT 31.1 - Inhibitor Therapeutics, Inc. | d328204dex311.htm |
| EX-13.1 - EXHIBIT 13.1 - Inhibitor Therapeutics, Inc. | d328204dex131.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of Commonwealth Biotechnologies, Inc. for the years ended December 31, 2011 and 2010 of our report dated April 11, 2012 included in its Registration Statement on Form S-8 (No. 333-51074) and S-3 (No. 333-51078) relating to the financial statements for the years then.
Richmond, Virginia
April 13, 2012